Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Chromosome loop control of oncogenic MYC produces a common vulnerability in diverse cancers

ABSTRACT: Chromosome loop control of oncogenic MYC produces a common vulnerability in diverse cancers

PROVIDER: PRJNA358692 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR5128273.fastq.gz	Fastqsanger.gz
	SRR5128274.fastq.gz	Fastqsanger.gz
	SRR5128275.fastq.gz	Fastqsanger.gz
	SRR5128276.fastq.gz	Fastqsanger.gz
	SRR5128277.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 25

Similar Datasets

Chromosome loop control of oncogenic MYC produces a common vulnerability in diverse cancers [HiChIP]

Project description:Chromosome loop control of oncogenic MYC produces a common vulnerability in diverse cancers [HiChIP]

| PRJNA438926 | ENA

Chromosome loop control of oncogenic MYC produces a common vulnerability in diverse cancers [HiChIP]

Project description:The majority of human cancers become highly dependent on a deregulated MYC oncogene, thus identifying a common mechanism underlying MYC regulation could provide valuable targets for therapy. We show here that diverse tumor-specific super-enhancers acquired throughout the 3Mb MYC insulated neighborhood functionally interact with a single conserved site occupied by CTCF protein in the MYC promoter. CRISPR-mediated deletion analysis shows that this common CTCF site is required for super-enhancer looping to the MYC promoter, high MYC expression and rapid cell proliferation in multiple cancers. Targeted methylation of the MYC enhancer anchor by a dCAS9-DNMT3A-3L fusion protein abrogates CTCF binding with consequent loss of MYC expression, suggesting a common vulnerability and a novel approach for therapeutic targeting of aggressive cancers.

2018-03-20 | GSE112000 | GEO

Chromosome loop control of oncogenic MYC produces a common vulnerability in diverse cancers [4C-seq]

2016-12-24 | GSE92880 | GEO

Chromosome loop control of oncogenic MYC produces a common vulnerability in diverse cancers [ChIP-seq]

2016-12-24 | GSE92879 | GEO

Chromosome loop control of oncogenic MYC produces a common vulnerability in diverse cancers

Project description:This SuperSeries is composed of the SubSeries listed below.

2016-12-24 | GSE92881 | GEO

Homo sapiens

Project description:Chromosome loop control of oncogenic MYC produces a common vulnerability in diverse cancers [ChIP-seq]

| PRJNA358712 | ENA

Homo sapiens

Project description:Chromosome loop control of oncogenic MYC produces a common vulnerability in diverse cancers [4C-seq]

| PRJNA358713 | ENA

Excessive transcription-replication conflicts are a vulnerability of BRCA1-mutant cancers

Project description:Excessive transcription-replication conflicts are a vulnerability of BRCA1-mutant cancers

| PRJNA724717 | ENA

Hotspot mutations induce metabolic reprogramming and vulnerability to serine deprivation

Project description:Cancer-associated mutations in the spliceosome gene create a neomorphic protein that produces aberrant mRNA splicing in hundreds of genes, but the ensuing biologic and therapeutic consequences of this missplicing are not well understood. Here we provide evidence that aberrant splicing by mutant alters the transcriptome, proteome, and metabolome of human cells, leading to missplicing-associated downregulation of metabolic genes, decreased mitochondrial respiration, and suppression of the serine synthesis pathway. We also find that mutant induces vulnerability to deprivation of the nonessential amino acid serine, which is mediated by missplicing-associated downregulation of the serine synthesis pathway enzyme PHGDH. This vulnerability is manifest both in vitro and in vivo, as dietary restriction of serine and glycine in mice is able to inhibit the growth ofMUT xenografts. These findings describe a novel role for mutations in altered energy metabolism, and they offer a new therapeutic strategy againstMUT cancers.

2019-12-31 | GSE134475 | GEO

Synthetic lethal screen reveals selective vulnerability of ATRX-mutant cancers to WEE1 inhibition

Project description:Synthetic lethal screen reveals selective vulnerability of ATRX-mutant cancers to WEE1 inhibition

| PRJNA459530 | ENA